Status:

RECRUITING

3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascularisation.

Lead Sponsor:

London North West Healthcare NHS Trust

Conditions:

Carotid Atherosclerosis

Ultrasound

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Atherosclerotic plaques, the build-up of fatty materials within our arteries, can develop over a long period of time without causing any symptoms. These plaques may continue to grow and rupture causi...

Eligibility Criteria

Inclusion Criteria:

  1. Age>18 years old.
  2. Previously consent for participation in the SECURE trial and have undergone carotid CEUS.
  3. Found to have at least one carotid plaque present on carotid CEUS.
  4. Able to give informed consent to participate in the study and its procedures.

Exclusion Criteria:

  1. Age <18 years old.
  2. Unable to provide informed consent to participate in the study and its procedures.
  3. Allergy to microbubble contrast agents.
  4. Known pregnancy.

Key Trial Info

Start Date :

October 16 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT07298655

Start Date

October 16 2025

End Date

September 30 2026

Last Update

April 13 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwick Park Hospital

Harrow, United Kingdom, HA1 3UJ

3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascularisation. | DecenTrialz